EUS-guided fine-needle core liver biopsy sampling using a novel 19-gauge needle with modified 1-pass, 1 actuation wet suction technique

Nieto, José; Khaleel, Huda; Challita, Youssef; Jimenez, Melissa; Baron, Todd H.; Walters, Laura; Hathaway, Kelli; Patel, Khushboo; Lankarani, Ali; Herman, Michael; Holloman, David; Saab, Sammy

doi:10.1016/j.gie.2017.05.013

Cited by 70 publications

(72 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Endoscopic ultrasonography (EUS) has become an indispensable diagnostic method in gastroenterology and new indications for EUS continue to emerge [1]. There has been a sustained progress in EUS diagnostic, potential due to constantly improving imaging systems and needles, which resulted in better tissue acquisition and lower technical failure rate [2][3][4][5][6][7]. Ultrasonography (US) or computed tomography (CT) guided liver biopsy are frequently used for the diagnosis of focal liver lesions.…”

Section: Introductionmentioning

confidence: 99%

Accuracy of endoscopic ultrasound-guided biopsy of focal liver lesions

et al. 2020

View full text Add to dashboard Cite

Aim: Endoscopic ultrasound (EUS) has become an indispensable method for diagnosis in gastroenterology and new indications for EUS continue to emerge. However, there are limited data regarding the accuracy of EUS-guided biopsy of hepatic focal lesions. The aim of this study was to assess the diagnostic yield of EUS-guided fine needle aspiration (FNA) of focal liver lesions.Material and methods: We conducted a prospective study in which patients with focal liver lesions, detected by transabdominal ultrasound and computed tomography or magnetic resonance imaging, underwent EUS-guided FNA to determine the diagnostic yield of the procedure.Results: In 47/48 of patients, the results of EUS-FNA were positive for malignancy, while in one case the acquired fragment was insufficient for appropriate histological analysis. Diagnostic yield was 0.98. In 83% of the cases biopsies were taken from the left lobe and in 17% from the right lobe with the same technical success rate. The most common diagnosis was metastatic adenocarcinoma of the pancreas (26% cases) followed by cholangiocarcinoma (17% cases). Concurrent sampling of other sites in addition to the liver and/or primary tumor was realized in 35% of the cases, with results that correlated with the liver biopsy and with the primary tumor biopsy. We reported no immediate or long-term complications in any of the patients.Conclusions: EUS guided fine needle aspiration/biopsy of focal liver lesions is safe, provides a very high diagnostic accuracy and should not be considered only as a rescue method after failure of percutaneous guided biopsies.

show abstract

Section: Introductionmentioning

confidence: 99%

Accuracy of endoscopic ultrasound-guided biopsy of focal liver lesions

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Two patients in the TCB arm developed abdominal pain after the biopsy. 74 In another recent study, Nieto et al 75 used the Sharkcore (Medtronic, Dublin, Ireland) newly developed biopsy needle with a modified one pass wet suction technique in 165 patients. The median of the maximum intact core tissue length obtained was 24 mm (18-35 mm).…”

Section: Eus For the Evaluation Of Parenchymal Liver Diseasesmentioning

confidence: 99%

“…Adverse events were uncommon (1.8%), and included abdominal pain and selflimited hematoma. 75 The superiority of the Sharkcore needle in obtaining CPTs over the 19-gauge Procore, standard 19-gauge needles, and two different percutaneous 18-gauge needles has been reported in an animal study by Schulman et al 78 Moreover, in another recent study by Pineda et al, 79 EUS-LB using a 19gauge FNA needle of both lobes produced significantly more tissue in term of both TSL and CPTs as compared with both percutaneous needles and those utilized for the transjugular route.…”

Section: Eus For the Evaluation Of Parenchymal Liver Diseasesmentioning

confidence: 99%

Endoscopic Ultrasound for the Hepatologist: A Comprehensive Review

et al. 2018

View full text Add to dashboard Cite

In the last few years, the diagnostic and therapeutic utilization of endoscopic ultrasound (EUS) for a variety of liver conditions has exponentially grown. We performed a thorough search for all available studies on the performance of diagnostic and therapeutic EUS in the field of hepatology. This article reviews the indication of EUS in the evaluation and treatment of portal hypertension, portal vein pressure measurement, focal liver lesions, and parenchymal liver diseases, and presents all the clinical evidences available so far in this regard. All the review data suggest that EUS is becoming an increasingly important tool in the armamentarium of the hepatologists for the management of certain liver-related conditions. Implementation in the education of the hepatologists of means to become more familiar with both diagnostic and therapeutic capabilities of EUS is warranted.

show abstract

“…The first report was by Mathew in 2005 for two patients who underwent either EUS or endoscopic retrograde pancreaticography (ERCP) for evaluation of abnormal liver enzymes . Since then, multiple studies have shown the efficacy of EUS‐guided liver biopsy with specimens showing diagnostic yield of 90–100% and a low rate of adverse events . Comparisons between the total specimen length and number of complete portal triads in the literature to date can be found in Table .…”

Section: Eus‐guided Liver Biopsymentioning

confidence: 99%

“…Factors include needle gauge, needle type, the use of suction, minimal number of passes, and whether right and left liver lobes need to be sampled. In one study, a “wet suction” technique with a single pass using a core needle was able to produce a median total specimen length of 60 mm with 84% of samples having more than 10 complete portal triads . Further studies will be needed to determine the optimal technique, but overall, it appears EUS‐guided parenchymal liver biopsy is useful for clinical evaluation and can be performed safely at the time of a diagnostic EUS examination in the evaluation for biliary disease or abnormal liver chemistries.…”

Section: Eus‐guided Liver Biopsymentioning

confidence: 99%

Endoscopic ultrasound and the liver: current applications and beyond

Shah

Baron

2018

J Hepato Biliary Pancreat

Self Cite

View full text Add to dashboard Cite

The diagnosis and management of many gastrointestinal conditions has been augmented by the development of endoscopic ultrasound. Its role in the diagnosis and management of liver disease has been somewhat limited, but with the rapid development of therapeutic advancements it has quickly emerged as a useful tool in the management of complex hepatic conditions. This includes its use in the management of complications of portal hypertension as well as its use in liver lesions and cancer. In this paper, we review case studies, case series and trials for hepatic applications of endoscopic ultrasound to provide an overview of its utilization in this field and demonstrating its more novel applications for future use.

show abstract

EUS-guided fine-needle core liver biopsy sampling using a novel 19-gauge needle with modified 1-pass, 1 actuation wet suction technique

Cited by 70 publications

References 19 publications

Accuracy of endoscopic ultrasound-guided biopsy of focal liver lesions

Accuracy of endoscopic ultrasound-guided biopsy of focal liver lesions

Endoscopic Ultrasound for the Hepatologist: A Comprehensive Review

Endoscopic ultrasound and the liver: current applications and beyond

Contact Info

Product

Resources

About